Abeona Therapeutics
Stock Forecast, Prediction & Price Target
Abeona Therapeutics Financial Estimates
Abeona Therapeutics Revenue Estimates
Abeona Therapeutics EBITDA Estimates
Abeona Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3M N/A | $1.41M -52.86% | $3.5M 147.52% | Avg: $16.54M Low: $10.21M High: $25.12M avg. 372.66% | Avg: $89.65M Low: $63.53M High: $123.38M avg. 441.90% | Avg: $263.6M Low: $186.82M High: $362.79M avg. 194.03% | Avg: $402.1M Low: $284.98M High: $553.41M avg. 52.54% |
Net Income
% change YoY
| $-88.60M N/A | $-31.80M 64.10% | $-54.18M -70.35% | Avg: $-66.75M Low: $-36.98M High: $-23.73M avg. -23.18% | Avg: $-27.1M Low: $-18.38M High: $4.06M avg. 59.40% | Avg: $66.27M Low: $41.18M High: $98.70M avg. 344.57% | Avg: $121.22M Low: $75.32M High: $180.53M avg. 82.90% |
EBITDA
% change YoY
| $-54.05M N/A | $-44.68M 17.32% | $-50.57M -13.17% | Avg: $-9.92M Low: $-15.07M High: $-6.12M avg. 80.37% | Avg: $-53.79M Low: $-74.03M High: $-38.12M avg. -441.90% | Avg: $-158.16M Low: $-217.67M High: $-112.09M avg. -194.03% | Avg: $-241.26M Low: $-332.04M High: $-170.98M avg. -52.54% |
EPS
% change YoY
| -$22.5 N/A | -$4.05 82% | -$2.53 37.53% | Avg: -$1.44 Low: -$1.73 High: -$1.11 avg. 43.08% | Avg: -$0.42 Low: -$0.86 High: $0.19 avg. 71.06% | Avg: $3.1 Low: $1.93 High: $4.62 avg. 843.99% | Avg: $5.67 Low: $3.52 High: $8.44 avg. 82.90% |
Operating Expenses
% change YoY
| $60.37M N/A | $46.22M -23.43% | $49.03M 6.07% | Avg: $93.15M Low: $57.50M High: $141.45M avg. 89.99% | Avg: $504.81M Low: $357.77M High: $694.77M avg. 441.90% | Avg: $1.48B Low: $1.05B High: $2.04B avg. 194.03% | Avg: $2.26B Low: $1.60B High: $3.11B avg. 52.54% |
FAQ
What is Abeona Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 115.92% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -36.98M, average is -66.75M and high is -23.73M.
What is Abeona Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 265.28% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $10.21M, average is $16.54M and high is $25.12M.
What is Abeona Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 260.26% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.73, average is -$1.44 and high is $-1.11.